<?xml version="1.0" encoding="UTF-8"?>
<p id="Par28">In the current state of knowledge, topical nasal corticosteroid therapy for allergic rhinitis in children and adolescents with COVID-19 can be continued at the recommended posology [
 <xref ref-type="bibr" rid="CR1">1</xref>, 
 <xref ref-type="bibr" rid="CR2">2</xref>].
</p>
